- Filed
- Apr 22, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 22, 2026 | 27.94M sh |
| Shares Diluted | Q1 2026 · Feb 28, 2026 | 27.94M sh |
| Shares Diluted | Q1 2026 · Feb 28, 2025 | 27.94M sh |
| Operating Cash Flow | Q1 2026 · Feb 28, 2026 | −$36.79K |
| Operating Cash Flow | Q1 2026 · Feb 28, 2025 | −$36.05K |
| Cash And Equivalents | Q1 2026 · Feb 28, 2026 | $17.08K |
| Cash And Equivalents | Q1 2026 · Nov 30, 2025 | $28.87K |
| Stockholders Equity | Q1 2026 · Feb 28, 2026 | $120.03K |
| Stockholders Equity | Q1 2026 · Nov 30, 2025 | $116.89K |
| Stockholders Equity | Q1 2026 · Feb 28, 2025 | $608.04K |
| Stockholders Equity | Q1 2026 · Nov 30, 2024 | $940.33K |
| Current Liabilities | Q1 2026 · Feb 28, 2026 | $309.09K |
| Current Liabilities | Q1 2026 · Nov 30, 2025 | $278.25K |
| Total Liabilities | Q1 2026 · Feb 28, 2026 | $309.09K |
| Total Liabilities | Q1 2026 · Nov 30, 2025 | $278.25K |
| Current Assets | Q1 2026 · Feb 28, 2026 | $429.12K |
| Current Assets | Q1 2026 · Nov 30, 2025 | $395.13K |
| Total Assets | Q1 2026 · Feb 28, 2026 | $429.12K |
| Total Assets | Q1 2026 · Nov 30, 2025 | $395.13K |
| Eps Diluted | Q1 2026 · Feb 28, 2026 | $0.00 |
| Eps Diluted restated | Q1 2026 · Feb 28, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Feb 28, 2026 | $0.00 |
| Eps Basic restated | Q1 2026 · Feb 28, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Feb 28, 2026 | $39.33K |
| Sga Expense | Q1 2026 · Feb 28, 2025 | $110.67K |
| Net Income | Q1 2026 · Feb 28, 2026 | $3.15K |
| Net Income | Q1 2026 · Feb 28, 2025 | −$392.3K |
| Operating Income | Q1 2026 · Feb 28, 2026 | −$39.33K |
| Operating Income | Q1 2026 · Feb 28, 2025 | −$110.67K |
| Cost Of Revenue | Q1 2026 · Feb 28, 2026 | $0 |
| Cost Of Revenue | Q1 2026 · Feb 28, 2025 | $0 |
| Revenue | Q1 2026 · Feb 28, 2026 | $0 |
| Revenue | Q1 2026 · Feb 28, 2025 | $0 |